JPH05500669A - ブデソニドの製造方法 - Google Patents
ブデソニドの製造方法Info
- Publication number
- JPH05500669A JPH05500669A JP2514161A JP51416190A JPH05500669A JP H05500669 A JPH05500669 A JP H05500669A JP 2514161 A JP2514161 A JP 2514161A JP 51416190 A JP51416190 A JP 51416190A JP H05500669 A JPH05500669 A JP H05500669A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- water
- formulas
- catalyst
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title description 5
- 229960004436 budesonide Drugs 0.000 title description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 6
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- PTOSIOCXWJMROU-GQDVPIKJSA-N (8s,9s,10r,13s,14s,17s)-17-(2,2-dihydroxyacetyl)-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)C(O)O)[C@@H]4[C@@H]3CCC2=C1 PTOSIOCXWJMROU-GQDVPIKJSA-N 0.000 claims 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 claims 1
- 239000000047 product Substances 0.000 description 9
- RFPQEXNUIMCZDQ-UHFFFAOYSA-N ac1ne2g0 Chemical compound CCC[CH2-] RFPQEXNUIMCZDQ-UHFFFAOYSA-N 0.000 description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- SEKYBDYVXDAYPY-ILNISADRSA-N (8s,9s,10r,11s,13s,14s,16r,17s)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 SEKYBDYVXDAYPY-ILNISADRSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Load-Bearing And Curtain Walls (AREA)
- Paper (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1)溶媒中で触媒の存在下に下記式 ▲数式、化学式、表等があります▼ を有する11β,16α,17α,21−テトラヒドロキシプレグナ−1,4− ジエン−3,20−ジオンをブタナールCH3CH2CH2CHOと反応させる ことによる下記式▲数式、化学式、表等があります▼ を有する(22R,S)−16α,17α−ブチリデンジオキシ−11β,21 −ジヒドロキシプレグナ−1,4−ジエン−3,20−ジオンの製造において、 該反応をアセトニトリル中で触媒としてp−トルエンスルホン酸を用いて実施す ることを特徴とする上記の製造方法。 2)反応を水の添加および反応混合物のpH調整により停止させることを特徴と する請求項1記載の方法。 3)反応の停止後に得られた結晶を濾去し、メチレンクロライドおよびメタノー ル中に溶解し次にリグロイン、ヘキサン、シクロヘキサンまたはヘプタンのよう な適当な炭化水素を加えることにより結晶化して粗生成物を得、ついでそれをメ タノール/水中で再結晶して純粋なプデソニドを得ることを特徴とする請求項1 または2記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903219-7 | 1989-10-02 | ||
SE8903219A SE8903219D0 (sv) | 1989-10-02 | 1989-10-02 | Process for the manufacture of budesonide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05500669A true JPH05500669A (ja) | 1993-02-12 |
JP2965352B2 JP2965352B2 (ja) | 1999-10-18 |
Family
ID=20377019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2514161A Expired - Lifetime JP2965352B2 (ja) | 1989-10-02 | 1990-09-27 | ブデソニドの製造方法 |
Country Status (25)
Country | Link |
---|---|
US (1) | US5556964A (ja) |
EP (1) | EP0494942B1 (ja) |
JP (1) | JP2965352B2 (ja) |
KR (1) | KR0160527B1 (ja) |
AT (1) | ATE130310T1 (ja) |
AU (1) | AU632864B2 (ja) |
BG (1) | BG61608B1 (ja) |
BR (1) | BR9007700A (ja) |
CA (1) | CA2065861C (ja) |
CY (1) | CY2084B1 (ja) |
DE (1) | DE69023664T2 (ja) |
DK (1) | DK0494942T3 (ja) |
ES (1) | ES2079491T3 (ja) |
FI (1) | FI103204B1 (ja) |
HK (1) | HK52097A (ja) |
HU (1) | HU212576B (ja) |
LT (1) | LT3697B (ja) |
LV (1) | LV10283B (ja) |
NO (1) | NO178827C (ja) |
RO (1) | RO110947B1 (ja) |
RU (1) | RU2048472C1 (ja) |
SE (1) | SE8903219D0 (ja) |
SG (1) | SG43344A1 (ja) |
UA (1) | UA26860C2 (ja) |
WO (1) | WO1991004984A1 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028190A (en) | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
US6166024A (en) | 1995-03-30 | 2000-12-26 | Mayo Foundation For Medical Education And Research | Use of topical azathioprine and thioguanine to treat colorectal adenomas |
IT1291288B1 (it) | 1997-04-30 | 1999-01-07 | Farmabios Srl | Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22. |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
US6266556B1 (en) | 1998-04-27 | 2001-07-24 | Beth Israel Deaconess Medical Center, Inc. | Method and apparatus for recording an electroencephalogram during transcranial magnetic stimulation |
FR2782823B1 (fr) | 1998-09-01 | 2000-11-17 | Neopost Ind | Procede d'impression thermique |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US6804458B2 (en) | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
ATE446581T1 (de) * | 2004-03-12 | 2009-11-15 | Trinity College Dublin | Magnetoresistives medium |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070191599A1 (en) * | 2006-02-15 | 2007-08-16 | Verus Pharmaceuticals, Inc. | Methods of manufacturing cortiscosteroid solutions |
CN102060906B (zh) * | 2010-12-23 | 2013-01-16 | 鲁南贝特制药有限公司 | 一种r布地奈德的制备方法 |
US10233210B2 (en) * | 2015-01-30 | 2019-03-19 | Coral Drugs Pvt. Ltd. | Process for preparation of glucocorticoid steroids |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3197469A (en) * | 1958-08-06 | 1965-07-27 | Pharmaceutical Res Products In | 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor |
US3077471A (en) * | 1961-08-04 | 1963-02-12 | Olin Mathieson | Steroids of the 19-norpregnane series |
SE378109B (ja) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
SE8008524L (sv) * | 1980-12-04 | 1982-06-05 | Draco Ab | 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand |
IT1196142B (it) * | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
SE8604059D0 (sv) * | 1986-09-25 | 1986-09-25 | Astra Pharma Prod | A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives |
-
1989
- 1989-10-02 SE SE8903219A patent/SE8903219D0/xx unknown
-
1990
- 1990-09-27 CA CA002065861A patent/CA2065861C/en not_active Expired - Lifetime
- 1990-09-27 KR KR1019920700728A patent/KR0160527B1/ko not_active IP Right Cessation
- 1990-09-27 UA UA94010159A patent/UA26860C2/uk unknown
- 1990-09-27 RO RO92-200446A patent/RO110947B1/ro unknown
- 1990-09-27 AU AU65309/90A patent/AU632864B2/en not_active Expired
- 1990-09-27 BR BR909007700A patent/BR9007700A/pt not_active IP Right Cessation
- 1990-09-27 AT AT90915222T patent/ATE130310T1/de not_active IP Right Cessation
- 1990-09-27 RU SU905011922A patent/RU2048472C1/ru active
- 1990-09-27 HU HU9201064A patent/HU212576B/hu unknown
- 1990-09-27 DK DK90915222.5T patent/DK0494942T3/da active
- 1990-09-27 EP EP90915222A patent/EP0494942B1/en not_active Expired - Lifetime
- 1990-09-27 JP JP2514161A patent/JP2965352B2/ja not_active Expired - Lifetime
- 1990-09-27 WO PCT/SE1990/000619 patent/WO1991004984A1/en active IP Right Grant
- 1990-09-27 DE DE69023664T patent/DE69023664T2/de not_active Expired - Lifetime
- 1990-09-27 ES ES90915222T patent/ES2079491T3/es not_active Expired - Lifetime
- 1990-11-27 SG SG1996008769A patent/SG43344A1/en unknown
-
1992
- 1992-03-30 NO NO921233A patent/NO178827C/no not_active IP Right Cessation
- 1992-04-01 FI FI921426A patent/FI103204B1/fi active
- 1992-04-01 BG BG96166A patent/BG61608B1/bg unknown
-
1993
- 1993-06-30 LV LVP-93-858A patent/LV10283B/xx unknown
- 1993-12-30 LT LTIP1729A patent/LT3697B/lt not_active IP Right Cessation
-
1994
- 1994-12-16 US US08/357,773 patent/US5556964A/en not_active Expired - Lifetime
-
1997
- 1997-04-24 HK HK52097A patent/HK52097A/xx not_active IP Right Cessation
-
1998
- 1998-10-16 CY CY9802084A patent/CY2084B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05500669A (ja) | ブデソニドの製造方法 | |
CA2102400C (en) | Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes | |
JP2006515869A (ja) | 17α−アセトキシ−11β−(4−N,N−ジメチルアミノフェニル)−19−ノルプレグナ−4,9−ジエン−3,20−ジオンを得る方法 | |
Antonucci et al. | Δ5, 7-Steroids. XII. 1, 2 Steroidal Cyclic Ketals. I. Cyclic Ketals of Δ4, 7-3-Ketosteroids | |
JPS6220199B2 (ja) | ||
JPS5824595A (ja) | ステロイド化合物およびその製造方法 | |
JPS61129197A (ja) | プレグナン誘導体の製造方法 | |
US2708673A (en) | Process for the production of 11beta, 17alpha-dihydroxy-4-pregnene-3, 20-dione | |
IL23453A (en) | Process for the preparation of 17alpha-ethynyl-19-nor steroids | |
JP3340514B2 (ja) | Δ9(11)−ステロイド化合物の新製造法 | |
US2749356A (en) | Method of isolating and purifying keto steroids and new keto steroid compounds | |
NO143346B (no) | Fremgangsmaate ved fremstilling av thymosin alfa/1 | |
US3712928A (en) | Phenylcyclohexane derivatives and methods for their manufacture | |
EP0058097A2 (fr) | Nouveau procédé de préparation de 17alpha-hydroxy 17bêta-hydroxyacétyl stéroides et produits intermédiaires correspondants obtenus | |
US2881192A (en) | Method of isolating and purifying keto steroids and new keto steroid compounds | |
US2888472A (en) | Preparation of delta1-dehydrocortisone | |
JP2007517788A (ja) | 1,2−不飽和アザステロイド類の製造方法 | |
CN116120387A (zh) | 一种地屈孕酮的合成工艺 | |
JPS6352637B2 (ja) | ||
US2719856A (en) | Steroid ketal | |
JPS6227077B2 (ja) | ||
JPH0368596A (ja) | 14α‐ヒドロキシ‐4‐アンドロステン‐3,6,17‐トリオンの製造方法 | |
JPS5953271B2 (ja) | セスキテルペン誘導体及びその製造法 | |
JPH0153680B2 (ja) | ||
JPH0468296B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070813 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080813 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090813 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100813 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100813 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110813 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110813 Year of fee payment: 12 |